Form 8-K - Current report:
SEC Accession No. 0001104659-25-068530
Filing Date
2025-07-17
Accepted
2025-07-17 07:30:45
Documents
22
Period of Report
2025-07-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2521066d1_8k.htm   iXBRL 8-K 40201
2 EXHIBIT 1.1 tm2521066d1_ex1-1.htm EX-1.1 300852
3 EXHIBIT 4.1 tm2521066d1_ex4-1.htm EX-4.1 105164
4 EXHIBIT 4.2 tm2521066d1_ex4-2.htm EX-4.2 102452
5 EXHIBIT 4.3 tm2521066d1_ex4-3.htm EX-4.3 117877
6 EXHIBIT 5.1 tm2521066d1_ex5-1.htm EX-5.1 10883
7 EXHIBIT 99.1 tm2521066d1_ex99-1.htm EX-99.1 10481
8 EXHIBIT 99.2 tm2521066d1_ex99-2.htm EX-99.2 12087
12 GRAPHIC tm2521066d1_ex5img001.jpg GRAPHIC 4330
13 GRAPHIC tm2521066d1_ex5img002.jpg GRAPHIC 16137
14 GRAPHIC tm2521066d1_ex5img003.jpg GRAPHIC 3522
  Complete submission text file 0001104659-25-068530.txt   1074189

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA ganx-20250715.xsd EX-101.SCH 3038
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ganx-20250715_lab.xml EX-101.LAB 34239
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ganx-20250715_pre.xml EX-101.PRE 22374
24 EXTRACTED XBRL INSTANCE DOCUMENT tm2521066d1_8k_htm.xml XML 3790
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40237 | Film No.: 251128816
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)